Optogenetics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The Optogenetics Market is Segmented by Light Equipment (Laser and Light-emitting Diode), Actuator (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin), Sensor (Calcium (Aequorin, Cameleon, and Other Calcium Sensors), Chloride (Clomeleon), Membrane-gated (Mermaid), and Other Sensors), Application (Neuroscience, Behavioral Tracking, Retinal, Disease Treatment, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value in USD million for the above segments.

Optogenetics Market Size

Market Snapshot1
Study Period: 2018 - 2028
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 3.86 %

Major Players


*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and it's growth?

Optogenetics Market Analysis

The optogenetics market was valued at USD 522.5 million in 2021, and it is expected to reach USD 648.41 million by 2027, registering a CAGR of 3.86% during 2022-2027.

The COVID-19 pandemic is expected to impact the optogenetics market significantly. According to the article published by PUS University in February 2022 by Shanet Suzan Alex, SARS-CoV-2 causes neurological abnormalities and respiratory symptoms, with an 85% occurrence rate in Alzheimer's patients. As per the same source, SARS-CoV-2 infiltrated COVID-19 patients' cognitive centers, causing Alzheimer's-like phenotypes in those with no underlying conditions and exacerbating Alzheimer's neuropathology in those with Alzheimer's and autism. As a result of COVID-19 patients with neurological disorders, the mortality rate has increased, and the market has been significantly impacted.

The major factors driving the market's growth include the scope of optogenetics as a potential diagnostic tool in neurosciences, the rapid growth of advanced technologies, and the increasing use of multimodal imaging. Optogenetics technology has revolutionized neuroscience in the last few years by allowing researchers to control specific neurons in experimental animals. The ability to control neurons has revealed information about brain pathways involved in diseases such as depression, obsessive-compulsive disorders, Parkinson's disease, and other conditions. In neural research, optogenetic methods for monitoring synaptic activity have proven to be extremely useful in several neurological diseases.

It allows researchers to study how the neurological activity patterns within specific brain cells give rise to thoughts, behaviors, and memories at an unprecedented precision. Thus, it helps find cures and treatments for neurological and psychiatric disorders, such as depression, addiction, schizophrenia, and Parkinson's disease. For instance, according to the article published in Nature Communication in May 2020, titled “Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms,” the precision of optogenetics holds the promise of improved normalization of circuits that are dysfunctional in Parkinson's disease and its diagnosis, while the use of light rather than electricity (as in deep brain stimulation) may reduce the risk of unintended effects caused by non-specific influences. Thus, the use of optogenetics in the diagnosis of Parkinson's proved a potent tool used to diagnose brain activity.

Also, rising cases of neurological disorders such as Parkinson’s, Alzheimer's, epilepsy, and Duntington diseases may boost the market. According to the Parkinson's Foundation 2020, approximately 1.2 million people in the United States may have Parkinson's disease by 2030. In addition, according to the Alzheimer Society of Canada 2021, over 500,000 Canadians were living with dementia. By 2030, this number is expected to rise to 912,000. The Public Health Agency of Canada News release 2019 stated that, on average, nine seniors are diagnosed with dementia every hour in Canada. According to the National Institutes of Health, in May 2020, the estimated investment for neurosciences was USD 10,353 million in 202, a significant increase from the 2020 figures of USD 10,353 million. The increasing investment in neuroscience is expected to boost the demand for optogenetics usage as it is a novel method to identify neurological diseases. This factor is expected to boost the market’s growth.​

However, lack of awareness and the high costs of technology may be the major restraining factors for the market over the forecast period.

Optogenetics Industry Segmentation

As per the scope of the report, optogenetics refers to a range of optical techniques used to elicit a physiological response in targeted biological systems in the absence of pharmacology and electric stimulations. Optogenetics controls neural activity by combining genetic engineering and optical tools. It is widely used in neuroscience for the modulation of neural circuits with high precision and specificity. The optogenetics market is segmented by light equipment, actuator, sensor, application, and geography. The report also covers the estimated market sizes and trends for 17 countries globally. The report offers the value (USD million) for the above segments.

By Light Equipment
Light-emitting Diode (LED)
By Actuator
By Sensor
Calcium (Aequorin, Cameleon, and Other Calcium Sensors)
Chloride (Clomeleon)
Membrane-gated (Mermaid)
Other Sensors
By Application
Behavioral Tracking
Retinal Disease Treatment
Other Applications
By Geography
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Optogenetics Market Trends

This section covers the major market trends shaping the Optogenetics Market according to our research experts:

Light-emitting Diode (LED) Segment is Expected to Hold a Major Market Share in the Optogenetics Market

LEDs surpass lasers in every aspect, as they are cheaper, smaller, more reliable, and easier to control. They are being incorporated into implants, allowing untethered light delivery. Factors such as investment in technology, product launches, and research studies in the segment are expected to drive the segment’s growth, thus driving the market. For instance, in February 2020, a project was launched with a EUR 3.6 million grant to treat neurological conditions such as Alzheimer’s and Huntington’s disease by making brain cells controllable with red light. A laser can control the neurons and boost cognition. Simultaneously, brain cell activity can be monitored non-invasively using a spectrometer. Thus, launching such projects promotes technological innovation and advancement in the market, thus contributing to the market’s growth.

In January 2021, SYMBXX initiated two clinical trials in Adelaide, Australia, and Toronto, Canada, to develop laser light therapies to reduce the debilitating symptoms of Parkinson’s disease. The clinical trials focused on seeking regulatory approvals may drive the studied market during the forecast period. According to a study titled “Ultrafast laser-based transient perforation of cellular membranes for in-vivo neuromodulation,” published in January 2022, a near-infrared ultrafast laser micro irradiation platform can be used to deliver gene encoding for neuroprotective and anti-angiogenic pigment epithelium-derived factor (PEDF) molecule to the retina, which exhibited protection from different insults. The research studies expanding the scope of lasers will also contribute to the market’s growth.

Therefore, due to such factors, the studied market is anticipated to witness notable growth during the forecast period.

Optogenetics Market

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to lead the market due to the increasing use of optogenetic devices, primarily in academic and research labs, the high burden of chronic diseases in the region, and the collaborations and new product launches by key market players.

Increasing government initiatives in the neurological field are the key growth factors. Increasing funding allows multiple players to enter the market and provide innovative solutions to cater to patient needs. For instance, as per the National Center for Chronic Disease Prevention and Health Promotion (January 2021), 6 in 10 adults in the United States have a chronic disease, and 4 in 10 adults have two or more chronic diseases. These conditions cost USD 3.8 trillion to the country’s healthcare system every year, which may have a significant impact on the growth of the studied market.

According to the Alzheimer's Impact Movement report in July 2020, more than 5 million Americans are living with Alzheimer’s, and an estimated 16 million are seeking unpaid care. Alzheimer’s cost the nation USD 305 billion in 2020, including USD 206 billion in Medicare and Medicaid payments. The increasing patient population requires more care, increasing the demand for optogenetics, thus, boosting the market's growth Collaborations and agreements are another reason for the market's growth. For instance, in September 2021, NeuroLux Inc. announced its exclusive partnership with TSE Systems to integrate its wireless technology with TSE System’s IntelliCage and PhenoMaster platforms, providing optogenetic, pharmacology, telemetry, and other capabilities for cutting-edge behavioral neuroscience research. Such collaborations increase innovation due to the synchronization of key players’ resources, thus boosting the market.

Similarly, in June 2021, Nanoscope Therapeutics Inc., a clinical-stage biotechnology company that is developing gene therapies for the treatment of retinal diseases, announced that vision improvements for all evaluated advanced retinitis pigmentosa (RP) patients persisted for one year following a single intravitreal injection in a Phase 1/2a clinical study with Multi-Characteristic Opsin (MCO) to retinal cells. Such studies improve the advantages of optogenetics and boost the market.

Hence, all such factors are likely to boost the market’s growth.

Optogenetics Market2

Optogenetics Industry Overview

The optogenetics market is moderately consolidated due to the presence of various small and large players. Some players include Hubner Group (Cobolt Inc.), Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, Shanghai Laser & Optics Century Co. Ltd, and Thorlabs Inc.

Optogenetics Market Leaders

  1. Laserglow Technologies

  2. Coherent Inc.

  3. Thorlabs Inc.

  4. Gensight Biologics

  5. Noldus Information Technology

*Disclaimer: Major Players sorted in no particular order

opto landscape.png

Optogenetics Market News

  • In September 2021, TSE Systems, one of the leaders in advanced preclinical research equipment for metabolic and behavioral research, and NeuroLux, the developer of battery-free wireless optogenetics implants for preclinical research, announced an exclusive partnership that will change in vivo animal science.
  • In September 2021, Novartis acquired Arctos Medical, expanding its optogenetics portfolio to bring gene therapies to patients with severe vision loss.

Optogenetics Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Drivers

      1. 4.1.1 Potential Diagnostic Tool in the Field of Neurosciences

      2. 4.1.2 Rapid Growth of Advanced Technology

      3. 4.1.3 Increasing Use of Multimodal Imaging

    2. 4.2 Market Restraints

      1. 4.2.1 High Cost of Technology

      2. 4.2.2 Lack of Awareness

    3. 4.3 Porter's Five Forces Analysis

      1. 4.3.1 Threat of New Entrants

      2. 4.3.2 Bargaining Power of Buyers/Consumers

      3. 4.3.3 Bargaining Power of Suppliers

      4. 4.3.4 Threat of Substitute Products

      5. 4.3.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Light Equipment

      1. 5.1.1 Laser

      2. 5.1.2 Light-emitting Diode (LED)

    2. 5.2 By Actuator

      1. 5.2.1 Channelrhodopsin

      2. 5.2.2 Halorhodopsin

      3. 5.2.3 Archaerhodopsin

    3. 5.3 By Sensor

      1. 5.3.1 Calcium (Aequorin, Cameleon, and Other Calcium Sensors)

      2. 5.3.2 Chloride (Clomeleon)

      3. 5.3.3 Membrane-gated (Mermaid)

      4. 5.3.4 Other Sensors

    4. 5.4 By Application

      1. 5.4.1 Neuroscience

      2. 5.4.2 Behavioral Tracking

      3. 5.4.3 Retinal Disease Treatment

      4. 5.4.4 Other Applications

    5. 5.5 By Geography

      1. 5.5.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.5.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.5.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.5.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Hubner Group (Cobolt Inc.)

      2. 6.1.2 Coherent Inc.

      3. 6.1.3 Gensight Biologics

      4. 6.1.4 Laserglow Technologies

      5. 6.1.5 Noldus Information Technology

      6. 6.1.6 Judges Scientific PLC (Scientifica)

      7. 6.1.7 Shanghai Laser & Optics Century Co. Ltd

      8. 6.1.8 Bruker Corporation

      9. 6.1.9 Thorlabs Inc.

    2. *List Not Exhaustive

**Competitive Landscape Covers - Business Overview, Financials, Products, Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Optogenetics Market Research FAQs

The Global Optogenetics Market is studied from 2018 - 2028.

The Global Optogenetics Market is growing at a CAGR of 3.86% over the next 5 years.

The Global Optogenetics Market is valued at 648 Million USD in 2028.

Asia Pacific is growing at the highest CAGR over 2018 - 2028.

North America holds highest share in 2021.

Laserglow Technologies, Coherent Inc., Thorlabs Inc., Gensight Biologics, Noldus Information Technology are the major companies operating in Global Optogenetics Market.

Global Optogenetics Industry Report

Statistics for the 2023 Global Optogenetics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Optogenetics analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!